Key facts
- It has raised $1.0M; the latest was Accelerator/Incubator ($1.0M) in Nov 2025.
- Notable investors include 43North, Brunel University, James Watt, Santander UK.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Cosi Care
- ·The full record, as it builds
Funding rounds
No funding rounds for Cosi Care are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Cosi Care
Manufacturer of safe-scratching tools and itch relief products with sensory-based care intended to reduce skin damage from chronic itching. The company offers cooling massage devices designed to interrupt the itch-scratch cycle with a focus on non-invasive relief, ergonomic design, and skin-safe materials using a combination of cold therapy, tactile stimulation, and distraction techniques with physical support, enabling individuals with eczema and related conditions to manage discomfort and promote healing.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2018
- Employees
- 2
- Website
- cosi-care.com/
- Ownership
- Privately Held (backing)
Cosi Care doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Cosi Care shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Cosi Care in its N-PORT filings yet. We sweep new filings monthly.